日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Conformational Change of Complement C5 Is Required for Thrombin-Mediated Cleavage, Revealed by a Novel Ex Vivo Human Whole Blood Model Preserving Full Thrombin Activity

补体 C5 的构象变化是凝血酶介导的裂解所必需的,通过一种保留全部凝血酶活性的新型离体人全血模型揭示

Per H Nilsson, Christina Johnson, Quang Huy Quach, Alex Macpherson, Oliver Durrant, Soeren E Pischke, Hilde Fure, Anne Landsem, Grethe Bergseth, Camilla Schjalm, Linda M Haugaard-Kedström, Markus Huber-Lang, Jean van den Elsen, Ole-Lars Brekke, Tom Eirik Mollnes3

NHDL, a recombinant VL/VH hybrid antibody control for IgG2/4 antibodies

NHDL,一种用于IgG2/4抗体的重组VL/VH杂合抗体对照。

Corinna Lau ,Martin Berner McAdam ,Grethe Bergseth ,Algirdas Grevys ,Jack Ansgar Bruun ,Judith Krey Ludviksen ,Hilde Fure ,Terje Espevik ,Anders Moen ,Jan Terje Andersen ,Tom Eirik Mollnes

Eculizumab treatment efficiently prevents C5 cleavage without C5a generation in vivo

依库珠单抗治疗可有效防止 C5 裂解,且体内不会产生 C5a

Elena B Volokhina, Grethe Bergseth, Nicole C A J van de Kar, Lambertus P van den Heuvel, Tom Eirik Mollnes